Top Markets
Coin of the day
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Classement en actions #33635
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Prix de l'action
$0.03702159
Dernière synchronisation: 2024-01-29
Capitalisation boursière
$7.21M
Changement (1 jour)
-3.08%
Changement (1 an)
0.00%
Pays
AU
Échange Antisense Therapeutics Limited (ANP)

Catégorie

Historique du prix de l'action pour Antisense Therapeutics Limited (ANP)
Prix de clôture le plus élevé : $0.04 le 2024-01-01

Prix de clôture le plus bas : $0.89 le 2001-12-01
Historique du prix de l'action de Antisense Therapeutics Limited de 2001 à 2026
Performance annuelle du prix de l'action
Année Performance
2024 3.20%
2023 -37.05%
2022 -56.36%
2021 59.69%
2020 44.65%
2019 191.58%
2018 3.71%
2017 -27.93%
2016 -45.26%
2015 -30.97%
2014 -50.82%
2013 16.96%
2012 -52.56%
2011 252.85%
2010 -78.09%
2009 107.28%
2008 -31.61%
2007 18.43%
2006 15.79%
2005 -72.58%
2004 4.39%
2003 129.21%
2002 -69.82%
2001 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$161.44 23.08%
DE
$35.97 20.03%
JP
$225.32 37.71%
CH
$20.95 11.92%
IN